| Unlock ST Premium FREE Trial: Discover top stock picks & smart tools | |
| Good morning! U.S. stock futures fell Monday as investors assessed growing AI safety concerns, a potential slowdown in AI development, and rising oil prices. S&P 500 futures dropped 0.85%, Nasdaq-100 futures declined 1.83%, and Dow futures slipped 0.32%. Anthropic CEO Dario Amodei urged AI companies to slow development of advanced models, while OpenAI CEO Sam Altman called an IPO this year “ill-advised.” Oil prices surged nearly 4% after Saudi Arabia shut a key pipeline, with U.S. crude recently topping $100 per barrel. Last week, the Dow fell 1.6%, S&P 500 0.8%, and Nasdaq 0.7%. Traders see an 86% chance of a Fed rate hike. | |
|
Top 5 Digital Assets Set to Surge Through 2025–2026
Inside, you’ll discover:
- ✅ How institutional capital is reshaping the crypto landscape
- ✅ Five digital assets positioned to benefit from the next growth wave
- ✅ Smart strategies for early positioning before mainstream momentum builds
👉 Access Your Free Report Here
By following the links above, you’re opting in to receive valuable updates from **Wealthiest Investor News** plus 2 bonus subscriptions. Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Sponsored
| |
|
Elmet Group Co (ELMT) stock soared 35.89% to $22.00 in pre-market trading after announcing a strategic transaction with Blue Moon Metals and EQ Resources to unlock the value of the Springer Tungsten Complex in Nevada.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares are trading up 18.23% at $9.60 at the time of writing ahead of a conference call to discuss topline CANYON-1 data and the potential of CRB-913 in obesity.
Antelope Enterprise Holdings Ltd (AEHL) rose more than 10.12% to $8.60 in pre-market trading today after announcing the pricing of a $6.0 million convertible promissory note.
Scholar Rock Holding Corp (SRRK) jumped about 9.15% to $60.48 in pre-market trading Monday after announcing FDA approval of ISEMBYLD (apitegromab-mstn) for adults and children aged 2+ with SMA receiving SMN2-targeted treatment.
| |
|
5 Stocks Under $10 With Big Upside Potential
You don't need a three-digit share price to find an interesting company. This free report reveals 5 stocks currently trading below $10, each with a specific catalyst that could put significantly higher prices within reach.
See why they're on our radar now.
Download Free Report
Sponsored
| |
| Top Upgrades & Downgrades | |
|
Barrington Research turned bullish on Copart Inc (CPRT), upgrading the stock to Outperform and assigning a $40 price target, representing potential upside of 33.56% from Sunday's close.
International Paper Co (IP) has won the favor of BofA Securities' equity research team. The firm upgraded the shares from Neutral to Buy and moved its price target to $46, suggesting 33.88% additional upside for the stock.
Wedbush reduced its rating on Check Point Software Technologies Ltd (CHKP) stock to Neutral from Outperform and assigned the price target to $135.
Wedbush analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Dynatrace, Inc (DT) has been changed to Neutral from Outperform and the new price target is set at $54.
Analysts at Wedbush downgraded Fortinet Inc (FTNT) stock to Neutral from Outperform, and the new price target is set at $155.
| |
|
Hyperscale Data Inc (GPUS) Executive Chairman, AULT MILTON C III declared the purchase of shares taking place on Sep 11 '26 at $0.19 for some 150000 shares. The transaction amount was around $28,380.
Fold Holdings Inc (FLD) Director, Young Bracebridge H Jr bought on Sep 11 '26 a total of 20000 shares at $0.55 on average. The purchase cost the insider an estimated $11,049.
IONQ Inc (IONQ) Special Advisor, Raymond John W, announced the sale of shares taking place on Sep 10 '26 at $37.21 for some 2407 shares. The total came to more than $89,564.
Natera Inc (NTRA) EXECUTIVE CHAIRMAN, Rabinowitz Matthew sold on Sep 11 '26 a total 50000 shares at $327.97 on average. The insider’s sale generated proceeds of almost $16.4 million.
| |
|
Adam Mesh has six open options trades on the book right now.
Every one of them is in the green.
Here's his 2026 record as of today:
• SNDA — opened Feb 26. +203. Still open.
• OWL — opened March 5. +735. Still open.
• BB — opened April 21. +474. Still open.
• ASPI — opened April 23. +800. Still open.
• NOK — opened April 30. +480. Still open.
• BULL — opened May 14. +156. Still open.
Total unrealized profit across the book: $2,848 and counting.
That's not a back-tested track record. Those are live open positions, dated and verifiable.
He'll be the first to tell you not every trade wins. He's been doing this for 30 years. He's had plenty of losers. Every trader has.
But the math behind his core strategy is built so the odds lean in his favor before he ever clicks submit.
He just put together a free video that walks through the four strategies behind every name on that list.
You'll see the trade structure. The setups. The exit rules. The reasons most options traders blow up their accounts and how to not be one of them.
Watch the free options video breakdown - drop your email to start →
Sponsored
| |
|
Top US earnings releases scheduled for today include Dave and Buster's Entertainment, Inc (PLAY). It will announce its July 2026 financial results. The company is expected to report earnings of $0.19 per share from revenues of $556.83M in the three-month period.
Analysts expect High Tide Inc (HITI) to report a net income (adjusted) of $0.02 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended July 2026 is predicted to come in at $194.58M.
Kestra Medical Technologies Ltd (KMTS), due to announce earnings after the market closes today, is expected to report earnings of -$0.62 per share on revenues of $29.01M for the recently concluded three-month period.
| |
| That's it for today. Thanks for reading. Good luck out there! Best Regards, Stocks Telegraph Team | |
| Disclaimer: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. | |
|